Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-25 to 2024-01-30
Current total value of award: $635218.92
Description: 8510401546!ADENOVIRUS TYPE 4 A